From: Regulation and therapy, the role of JAK2/STAT3 signaling pathway in OA: a systematic review
Classification | Name | Effect on JAK2/STAT3 | Mechanism | Consequence | References |
---|---|---|---|---|---|
MicroRNAs | MiR-375 inhibition | activation | ADAMTS-5↓, MMP-13↓, COL-II↑, AGG↑, p-JAK2/JAK2↑, p-STAT3/STAT3↑, Bcl-2/Bax↑ | Improved the ability of chondrocytes to antagonize oxidative stress and maintain ECM homeostasis | |
MiR-149-5p | Inhibition | AGT↓, ANGII, AT1R | Regulated and combined AGT, promoted the inflammatory responses induced by IL-6 | [39] | |
MiR-216a-5p | Inhibition | Bax↓, Caspase-3↓, Bcl-2↑ | Promoted the proliferation and migrations well as inhibited apoptosis in chondrocytes | [29] | |
MiR-224-5p | Inhibition | MMP-9↓, MMP-13↓, COL-II↑, AGG↑, Caspase-3↓, Circ_PDE1C↓ | Inhibited chondrocytes apoptosis and ECM degradation. Targeted CCL2 and accelerated cartilage degradation | [44] | |
Traditional Chinese medicine | Danshen | activation | P-JAK2, p-STAT3↓, GSH, SOD, CAT↑, Bcl-2↑, Bax, caspase3, PARP↓ | Attenuated cartilage injuries by activating JAK2/STAT3 pathway | [71] |
Diosgenin | activation | P-JAK2, p-STAT3, SDH, COX, SOD↑, Bax↓ | Protected OA cartilage cells by activating the JAK2/STAT3 pathway, which effectively reduces mitochondrial oxidative stress damage and apoptosis in OA cells during the pathological process | [73] | |
curcumin | activation | P-JAK2, p-STAT3, | Increased the mitochondrial resistance to oxidative stress in chondrocytes, significantly slows down the degeneration of articular cartilage, and reduces the level of OA progression | [75] | |
Resveratrol | Inhibition | JAK2, STAT3, SOCS3, MMP-13↓ | No significant leptin resistance existed in articular cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway | [77] | |
Inhibitors | AG490 | Inhibition | JAK2↓ | Inhibited JAK2/STAT3 activation and apoptosis in chondrocytes induced by IL-1β | |
WP1066 | Inhibition | JAK2, STAT3↓ | Downregulated the expression of JAK2/STAT3 to suppress the chondrocytic inflammation responses induced by IL-6 | [39] | |
Tofacitinibis | Inhibition | JAK, STAT3↓ | Moderated chondrogenic hypertrophy in human chondrocyte lines via downregulation of JAK/STAT3 | [68] | |
Pranlukast | Inhibition | JAK2, STAT1↓ | Reversed the enhancement levels of pro-inflammatory cytokines to prevent the progression of OA | [81] | |
STA21 | Inhibition | STAT3↓ | Blocked STAT3 dimerization and DNA binding to alleviate joint pain and cartilage damage | [82] | |
Stattic | Inhibition | STAT3↓ | Reduced the severity of OA cartilage lesions and decreased the size of osteophytes. Stattic had no significant effect on the synovium or the subchondral bone | [55] |